Current Report Filing (8-k)
June 17 2022 - 4:17PM
Edgar (US Regulatory)
0001787740
false
0001787740
2022-06-14
2022-06-14
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June
14, 2022
TIVIC HEALTH SYSTEMS, INC.
(Exact name of registrant as specified in its
charter)
Delaware |
|
001-41052 |
|
81-4016391 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
25821 Industrial Blvd., Suite 100
Hayward, CA 94545
(Address of principal executive offices, including
zip code)
Registrant’s telephone number, including
area code: (888) 276-6888
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading symbol(s) |
|
Name of each exchange
on which registered |
Common Stock, par value $0.0001 per share |
|
TIVC |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company x
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.07 Submission
of Matters to a Vote of Security Holders
On June 14, 2022, Tivic
Health Systems, Inc. (the “Company”) held its 2022 Annual Meeting of Stockholders (the “Annual Meeting”) in a
virtual format. At the close of business on April 18, 2022, the record date for the Annual Meeting, there were 9,621,484 shares of Company
common stock issued and outstanding, which constituted all of the issued and outstanding capital stock of the Company as of the record
date. At the Annual Meeting, 5,388,372 of the Company’s 9,621,484 outstanding shares of common stock entitled to vote as of the
record date, or approximately 56.0%, were represented by proxy or in person (virtually), and, therefore, a quorum was present.
The proposals voted on
at the Annual Meeting are more fully described in the Definitive Proxy Statement on Schedule 14A filed by the Company with the Securities
and Exchange Commission (the “Commission”) on May 2, 2022, which information is incorporated herein by reference.
The final voting results
on the proposals presented for stockholder approval at the Annual Meeting were as follows:
Proposal
No. 1: The Company’s stockholders elected one Class I director, to hold office until the Company’s 2025 annual
meeting of stockholders, or until her successor is duly elected and qualified, subject to prior death, resignation or removal, as follows:
Nominees |
|
Votes For |
|
Votes
Withheld
|
|
Broker Non-Votes |
Karen Drexler |
|
4,540,661 |
|
133,823 |
|
713,888 |
Proposal
No. 2: The Company’s stockholders ratified the selection of Rosenberg Rich Baker Berman, P.A. as the Company’s
independent registered public accounting firm for the fiscal year ending December 31, 2022, as follows:
Votes For |
|
Votes
Against
|
|
Abstentions |
|
Broker Non-Votes |
5,252,909 |
|
129,771 |
|
5,692 |
|
0 |
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: June 17, 2022
|
TIVIC HEALTH SYSTEMS, INC. |
|
|
|
|
By: |
/s/ Veronica Cai |
|
|
Name: Veronica Cai |
|
|
Title: Chief Financial Officer |
Tivic Health Systems (NASDAQ:TIVC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tivic Health Systems (NASDAQ:TIVC)
Historical Stock Chart
From Apr 2023 to Apr 2024